Adenovirus-Vectored Vaccine Provides Postexposure Protection to Ebola Virus–Infected Nonhuman Primates

Ebola virus (EBOV) causes lethal disease in up to 90% of EBOV-infected humans. Among vaccines, only the vesicular stomatitis virus platform has been successful in providing postexposure protection in nonhuman primates. Here, we show that an adjuvanted human adenovirus serotype 5 (Ad5)–vectored vacci...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Infect Dis
Main Authors: Wong, Gary, Richardson, Jason S., Pillet, Stéphane, Racine, Trina, Patel, Ami, Soule, Geoff, Ennis, Jane, Turner, Jeffrey, Qiu, Xiangguo, Kobinger, Gary P.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2015
Assuntos:
Ebola and Marburg Viruses-Research, Outbreak Management, Epidemiology and Ecology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4564535/
https://ncbi.nlm.nih.gov/pubmed/25957963
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiv102
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados